About
A Biotech Venture Capital Leader
Based in Montréal, CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences currently manage $245 million of assets.
Source: CTI Life Sciences
Strategy
Out of the four inflection points indicated in the figure below, the Fund’s strategy will be to focus on two key junctures in the pharmaceutical development process highlighted in color namely and primarily: from Pre-clinical to Proof-of-Concept and secondarily on Proof-of-Concept to Phase III.
This strategy is based upon the following observations:
Large Pharmaceuticals
They constantly need new products to grow to meet financial expectations
Small Biotechs
They continue to be the main source of new ideas and innovations in the industry
Attractiveness
Product company focused investments have proven historically to be attractive
Return on Investment
To consider an investment, there needs to be a favorable risk/reward profile ratio
Source: CTI Life Sciences
Industry Focus
Biotechnology
Year Founded
2006
Contact Info
Key Personnel
Mr. Jean-François Leprince - Managing Partner
Dr. Janelle R. Anderson Ph.D. - Managing Partner and Partner
Dr. Shermaine Tilley Ph.D., MBA - Managing Partner
Mr. Ken Pastor - General Partner and Co- Founder